Dyslipidemia of type 2 diabetes mellitus (T2DM) is consequent to alterations in key processes of the plasma lipid metabolism modulated by insulin, such as lipolysis by lipoprotein lipase and hormone-sensitive lipase [1-3]. The gene discussed is LIPE; the disease is type 2 diabetes mellitus.